- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: melphalan
Total 817 results
-
BioInvent International ABTerminatedA Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple MyelomaMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); ViaCellCompleted
-
Nanfang Hospital of Southern Medical UniversityGuangzhou First People's Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen... and other collaboratorsUnknownMultiple Myeloma | Conditioning | Autologous Hematopoietic Stem Cell TransplantationChina
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
Federal State Budgetary Institution, Pulmonology...Moscow State University of Medicine and DentistryUnknownNon-cystic Fibrosis BronchiectasisRussian Federation
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)UnknownRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia and other conditionsUnited States
-
Xinqiao Hospital of ChongqingThe First Affiliated Hospital of Anhui Medical University; Nanfang Hospital... and other collaboratorsUnknownB-cell Lymphoma | B-cell Acute Lymphoblastic LeukemiaChina
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States, Italy
-
Columbia UniversityCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | CD19 PositiveUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Hodgkin Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | T-Cell Chronic Lymphocytic Leukemia | Recurrent Childhood Non-Hodgkin... and other conditionsUnited States, Germany
-
Edward-Elmhurst Health SystemCompletedSarcoma | Adenocarcinoma | Neoplasm Metastasis | Peritoneal NeoplasmsUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.Completed
-
Basque Health ServiceTerminated
-
M.D. Anderson Cancer CenterCompletedMultiple Myeloma | Primary AmyloidosisUnited States
-
Acrotech Biopharma Inc.CompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterCompletedLymphomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminated
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)WithdrawnLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Washington University School of MedicineTerminated
-
CelgeneCompletedMultiple MyelomaKorea, Republic of, United States, France, Belgium, Canada, Spain, United Kingdom, Australia, Italy, New Zealand, China, Portugal, Switzerland, Taiwan, Austria, Greece, Germany, Ireland, Sweden
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent... and other conditionsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; SmithKline BeechamCompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompletedInfection | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of Maryland, BaltimoreCompletedProstate CancerUnited States
-
Attaya SuvannasankhaCelgeneCompletedLenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple MyelomaMultiple MyelomaUnited States
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
University of Maryland, BaltimoreCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
University of Maryland, BaltimoreCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of Illinois at ChicagoTerminatedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Roswell Park Cancer InstituteCompletedPrimary Myelofibrosis | Polycythemia Vera | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma and other conditionsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
University of Maryland, BaltimoreKing Pharmaceuticals is now a wholly owned subsidiary of PfizerTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Lymphoma | CD20 Positive | Lymphocytic NeoplasmUnited States
-
University of ArizonaCompletedHematologic Neoplasms | Multiple Myeloma | Myelofibrosis | Anemia, Aplastic | Hemoglobinuria, ParoxysmalUnited States
-
Lymphoma Study AssociationCompletedLymphoma, Large-Cell, DiffuseUnited States, Australia, Belgium, Czechia, Finland, Germany, Israel, Sweden, Switzerland, United Kingdom
-
AmgenCompletedMultiple MyelomaKorea, Republic of, China, Spain, Taiwan, United States, Netherlands, Australia, Singapore, New Zealand, United Kingdom, Israel, France, Japan, Italy, Czechia, Belgium, Argentina, Austria, Bulgaria, Canada, Germany, Greece, Hungary, M... and more
-
Dutch Childhood Oncology GroupAssociazione Italiana Ematologia Oncologia Pediatrica; CPH, Czech republic; PINDA... and other collaboratorsUnknownLeukemiaUnited Kingdom, United States, Czechia, Belgium, Germany, Austria, France, Italy, Netherlands
-
M.D. Anderson Cancer CenterTerminatedNeuroblastomaUnited States
-
M.D. Anderson Cancer CenterBellicum PharmaceuticalsTerminatedLeukemia | Myeloma | Myeloproliferative DiseasesUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedWolman Disease | Adrenoleukodystrophy | Metachromatic Leukodystrophy | Sanfilippo Syndrome | GM1 Gangliosidosis | Globoid Cell Leukodystrophy | Tay Sachs Disease | Sandhoffs Disease | I-Cell DiseaseUnited States
-
Institute of Hematology & Blood Diseases HospitalUnknownMultiple Myeloma | Plasma Cell Leukemia | Extramedullary Plasmacytoma | Loss of Chromosome 17p | t(14;16) | t(4;14) | Complex Karyotype | T(14;20) | 1Q21 AmplificationChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedWaldenstrom Macroglobulinemia | Refractory Plasma Cell Myeloma | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Recurrent Plasma Cell Myeloma | Plasma Cell Leukemia and other conditionsUnited States